New bone graft material under scrutiny in 1,000-Patient spine study
NCT ID NCT06971835
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is tracking 1,000 people who received a bone graft material called Natural Matrix Protein (NMP) during spine surgery for degenerative disc disease. Researchers will monitor bone fusion, pain, and disability over two years to see if NMP is safe and helps the spine heal. Participants are already receiving NMP as part of their standard care, and this registry simply observes their outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Natural Matrix Protein (NMP) fibers and micro particulates, a bone graft material
What this could lead to
If successful, this could confirm that NMP is a safe and effective option to help bones fuse in spine surgery, potentially improving pain and disability outcomes.
What could go wrong
This is an observational registry, not a controlled trial, so results may be less reliable. It is also early-stage evidence for a product already in use, and individual results may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE (DDD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Spine Center of Louisiana
Baton Rouge, Louisiana, 70809, United States
-
Spine Institute of Louisiana
Shreveport, Louisiana, 71101, United States